Natural biodegradable polymers as matrices in transdermal drug delivery

International Journal of Drug Development and Research

Volumn 3, Issue 2, 2011, Pages 85-103

  Sharma, Kiran ^a   Singh, Vijender ^a   Arora, Alka ^a  

^a KRISHNA INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

Biodegradable polymers; Control release; Natural polymers; Transdermal drug delivery

Indexed keywords

AGAROSE; ALGINIC ACID; CELLULOSE; CHITIN; CHITOSAN; COLLAGEN; DEXTRAN; ETHYLENE VINYL ACETATE COPOLYMER; GELATIN; GLUCURONIC ACID; GUM COPAL; GUM DAMAR; HYALURONIC ACID; MACROGOL; PECTIN; POLY(METHYL METHACRYLATE); POLYACRYLAMIDE; POLYACRYLIC ACID; POLYMACON; POLYMER; POLYMETHACRYLIC ACID; POVIDONE; ROSIN; SHELLAC; SILK FIBROIN; STARCH; STIFFENER; UNCLASSIFIED DRUG; XANTUM GUM; ZEIN;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOSAFETY; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CONTROLLED DRUG RELEASE; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMIDITY; HYDROCOLLOID; HYDROGEL; HYDROLYSIS; MICROFLUIDICS; MOLECULAR WEIGHT; PH; PHYSICAL CHEMISTRY; STRATUM CORNEUM; STRUCTURE ANALYSIS; TEMPERATURE;

EID: 83055193767     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Cleary GW, Transdermal Delivery Systems: A Medical Rationale, in Topical Drug Bioavailability, Bioequivalence, and Penetration, Shah VP, and Maibach HI (eds), New York, Plenum, 1993, 17-68.
2. Kim SW, Temperature Sensitive Polymers for Delivery of Macromolecular Drugs, in Advanced Biomaterials in Biomedical Engineering and Drug Delivery Systems, Ogata N, Kim SW, Feijen J, et al. (eds), Tokyo, Springer, 1996, 126-133.
3. Heller J, Controlled Drug Release from Poly(ortho esters)-A Surface Eroding Polymer, J Controlled Release, 1985, 2, 167-177.
4. Baveja SR, Ranga RKV, Arora J, Examination ofnatural gums and mucilage's as sustaining materials intablet dosage forms, J Pharm Sci, 1989, 51, 4, 115-118.
5. Kakkar AP, Singh M, Medirrata A, Formulationoptimization of diltiazem Hydrochloride matrixtablets containing modified isphagula husk usingfactorial design, DevInd Pharm, 1997, 23, 11, 1055-1061.
6. Jain RA, The manufacturing techniques of variousdrug loaded biodegradable poly (lactide-coglycolide)(PLGA) devices, Biomaterials, 2000, 21, 2475-2490.
7. Berkland C, King M, Cox A, Kim K, Pack DW, Precise control of PLG microsphere size providesenhanced control of drug release rate, J. Control Release, 2002, 82, 137-147.
8. Clochard M, Dinand E, Rankin S, Simic S, Brocchini S, New strategies for polymerdevelopment in pharmaceutical science-a shortreview, J Pharm Pharmacol, 2001,53, 9,1175-1184.
9. Kathryn E. Uhrich, Scott M. Cannizzaro, Robert S. Langer, Polymeric Systems forControlled Drug Release, Chem. Rev, 1999, 99,3181-3198.
10. Gilding DK, Reed AM, BiodegradablePolymers for Use in Surgery Polyglycolic/Poly (lactic acid) Homo- andCopolymers, Polymer, 1979, 20, 1459-1484.
11. Kohn J, and Langer R, Bioresorbable and Bioerodible Materials, in Biomaterials Science:An Introduction to Materials in Medicine, RatnerBD, Hoffman AS, Schoen FJ, and Lemons JE(eds), New York, Academic Press, 1996, 64-72.
12. Pietrzak WS, Verstynen ML, and Sarver DR, Bioabsorbable Polymer Science for thePracticing Surgeon, J Craniofacial Surg, 1997, 8, 2,92.
13. Shingel KI, Marchessault RH, Robert H. Marchessault, Francois Ravenelle,Polysaccharides for DrugDelivery and Pharmaceutical Applications, ACSSymposium Series 934, American ChemicalSociety,Xiao Xia Zhu (Eds.), 2006, 271-287.
14. Vyas SP, Khar RK. Controlled DrugDelivery: Concepts and Advances. Ist ed.Vallabhprakashan, New Delhi, 2002, 156-189.
15. Khullar P, Khar RK and Agarwal SP, GuarGum as a hydrophilic matrix for preparation ofTheophylline Controlled Release dosage form, Ind. J. Pharm. Sc, 1999, 61, 6, 342-345.
16. Nokano M, Ogata A, In vitro releasecharacteristics of matrix tablets, Study ofKaraya gum and Guar gum as releasemodulators, Ind. J. Pharm. Sc, 2006,68, 6, 824-826.
17. Andreopoulos AG and Tarantili PA, XanthanGum as a Carrier for Controlled Release ofDrugs, J. Biomed, 2001, 16, 35.
18. Poddar RK, Rakha P, Singh SK, Mishra DN, BioadhesivePolymersas a Platform for Drug Delivery: Possibilitiesand Future Trends, Research J onPhamacetical Dosage Form andTechnology, 2010, 2,1, 40-54.
19. Ebihara et al., Controlled releaseformulations to increase the bioadhesiveproperties, Drug Res, 1983, 33, 163.
20. Satturwar PM, Fulzele SV, Dorle AK, Biodegradation and In Vivo Biocompatibility of Rosin: a Natural Film-Forming Polymer, AAPS PharmSciTech, 2003, 4, 50-55.
21. Atish S. Mundadai, Jasmine G. Avari, Evaluation of gum copal as rate controlling membrane for transdermal application: effect of plasticizers, ActaPharmaceuticaSciencia, 2010, 52, 31-38.
22. Mundada AS, Avari JG, DamarBatu as a novel matrix former for the transdermal drug delivery: in vitro evaluation, 2009, 35, 9, 1147-1154.
23. Gyung Don Kang, Ki Hoon Lee, Chang Seok Ki, Joong Hee Nahm, Young Hwan Park, Silk Fibroin/Chitosan Conjugate Crosslinked by Tyrosinase, Macromolecular Research, 2004, 12, 5, 534-539.
24. Majeti NV, Ravi Kumar, A review of chitin and chitosan applications, Reactive & Functional Polymers, 2000, 46, 1-27.
25. Elisangela C, Antonio J, Antonio A, Jose A, Luiz H, Preparation and characterization of thermoplastic starch/zein blends, Mat. Res., 2007, 10, 3, 1516-1439.
26. Graeme SM, John HC, John TF, The potential use of mixed films of pectin, chitosan and HPMC for bimodal drug release, Journal of Controlled Release,1999, 58, 3, 303-310.
27. Han B, Huang LLH, Cheung D, Cordoba F, Nimni M, Polypeptide growth factors with a collagen binding domain: Their potential for tissue repair and organ regeneration, In Zilla P and Greisler HP, editors. Tissue engineering of vascular prosthetic grafts. Austin: RG Landes, 1999, 287-299.
28. Mosahebi A, Simon M, Wiberg M, Terenghi G, A novel use of alginate hydrogel as Schwann cell matrix, Tissue Eng, 2001, 7, 525-534.
29. Sukumar Maiti, Safikur Rahman, Application of shellac in polymers, Polymer Reviews,1986, 26, 3, 441-481.
30. Mani Prabaharan,Chitosan Derivatives as Promising Materials for Controlled DrugDelivery, Journal of Biomaterials Applications,2008, 23, 1, 5-36.
31. Huang, JC, Shetty, AS, Wang, MS, Biodegradable plastics: A review, Advances inPolymer Technology, 1990, 10, 1, 23-30.
32. Ledward, DA, Properties and applications of compostable starch-based materials, Trends in Food Science and Technology, 1998, 41, 402-405.
33. Nechwatal, Mieck, K, Reubmann, T, Developments in the characteristics of natural fiber properties and in the use of natural fibers for composites, Composites Science andTechnology, 2003, 63, 1273-1279.
34. Sakiyama ES, Hubbell J, Functional biomaterials: Design of novel biomaterials, Annual Review of Materials Research, 2001, 3, 183-201.
35. Schroeter, J, Creating a framework for the widespread use of biodegradable polymers, Polymer Degradation and Stability, 1998, 59, 1, 377-381.
36. Vert M, Li S, and Garreau H, More About the Degradation of LA/GA-derived Matrices in Aqueous Media, J Controlled Release, 1991, 15-26.
37. Cleary GW, Transdermal Drug Delivery, Cosmetics and Toiletries, 106, 1991, 97-107.
38. Linshu L, Marshall L and Fishman B, Pectinin controlled drug delivery - a review, Journalof Control Release, 2007, 14, 15-24.